These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1. Liao HX; Tsao CY; Alam SM; Muldoon M; Vandergrift N; Ma BJ; Lu X; Sutherland LL; Scearce RM; Bowman C; Parks R; Chen H; Blinn JH; Lapedes A; Watson S; Xia SM; Foulger A; Hahn BH; Shaw GM; Swanstrom R; Montefiori DC; Gao F; Haynes BF; Korber B J Virol; 2013 Apr; 87(8):4185-201. PubMed ID: 23365441 [TBL] [Abstract][Full Text] [Related]
7. High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia. Nedellec R; Herbeck JT; Hunt PW; Deeks SG; Mullins JI; Anton ED; Reeves JD; Mosier DE AIDS Res Hum Retroviruses; 2017 Mar; 33(3):234-245. PubMed ID: 27604829 [TBL] [Abstract][Full Text] [Related]
8. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded. Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121 [TBL] [Abstract][Full Text] [Related]
9. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. Salazar-Gonzalez JF; Salazar MG; Keele BF; Learn GH; Giorgi EE; Li H; Decker JM; Wang S; Baalwa J; Kraus MH; Parrish NF; Shaw KS; Guffey MB; Bar KJ; Davis KL; Ochsenbauer-Jambor C; Kappes JC; Saag MS; Cohen MS; Mulenga J; Derdeyn CA; Allen S; Hunter E; Markowitz M; Hraber P; Perelson AS; Bhattacharya T; Haynes BF; Korber BT; Hahn BH; Shaw GM J Exp Med; 2009 Jun; 206(6):1273-89. PubMed ID: 19487424 [TBL] [Abstract][Full Text] [Related]
10. Key Positions of HIV-1 Env and Signatures of Vaccine Efficacy Show Gradual Reduction of Population Founder Effects at the Clade and Regional Levels. Han C; Johnson J; Dong R; Kandula R; Kort A; Wong M; Yang T; Breheny PJ; Brown GD; Haim H mBio; 2020 Jun; 11(3):. PubMed ID: 32518179 [TBL] [Abstract][Full Text] [Related]
11. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop. Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999 [TBL] [Abstract][Full Text] [Related]
12. Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers. Kumar A; Giorgi EE; Tu JJ; Martinez DR; Eudailey J; Mengual M; Honnayakanahalli Marichannegowda M; Van Dyke R; Gao F; Permar SR PLoS Pathog; 2021 Apr; 17(4):e1009478. PubMed ID: 33798244 [TBL] [Abstract][Full Text] [Related]
13. Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5. Parker ZF; Iyer SS; Wilen CB; Parrish NF; Chikere KC; Lee FH; Didigu CA; Berro R; Klasse PJ; Lee B; Moore JP; Shaw GM; Hahn BH; Doms RW J Virol; 2013 Mar; 87(5):2401-11. PubMed ID: 23269796 [TBL] [Abstract][Full Text] [Related]
15. High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. Li H; Bar KJ; Wang S; Decker JM; Chen Y; Sun C; Salazar-Gonzalez JF; Salazar MG; Learn GH; Morgan CJ; Schumacher JE; Hraber P; Giorgi EE; Bhattacharya T; Korber BT; Perelson AS; Eron JJ; Cohen MS; Hicks CB; Haynes BF; Markowitz M; Keele BF; Hahn BH; Shaw GM PLoS Pathog; 2010 May; 6(5):e1000890. PubMed ID: 20485520 [TBL] [Abstract][Full Text] [Related]
16. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs. Li H; Zony C; Chen P; Chen BK J Virol; 2017 May; 91(9):. PubMed ID: 28148796 [TBL] [Abstract][Full Text] [Related]
17. Characterization of HIV-1 CRF01_AE Sasaki M; Kotaki T; Khairunisa SQ; Tachibana S; Ophinni Y; Hayashi Y; Nasronudin ; Kameoka M AIDS Res Hum Retroviruses; 2020 Mar; 36(3):242-247. PubMed ID: 31580700 [TBL] [Abstract][Full Text] [Related]
18. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals. Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865 [TBL] [Abstract][Full Text] [Related]
19. Characterization of human immunodeficiency virus type 1 CRF01_AE env genes derived from recently infected Thai individuals. Chaitaveep N; Utachee P; Nakamura S; Chuenchitra T; Ekpo P; Takeda N; Pattanapanyasat K; Kameoka M Microbes Infect; 2014 Feb; 16(2):142-52. PubMed ID: 24513704 [TBL] [Abstract][Full Text] [Related]
20. Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants. Fouda GG; Mahlokozera T; Salazar-Gonzalez JF; Salazar MG; Learn G; Kumar SB; Dennison SM; Russell E; Rizzolo K; Jaeger F; Cai F; Vandergrift NA; Gao F; Hahn B; Shaw GM; Ochsenbauer C; Swanstrom R; Meshnick S; Mwapasa V; Kalilani L; Fiscus S; Montefiori D; Haynes B; Kwiek J; Alam SM; Permar SR Retrovirology; 2013 Jan; 10():3. PubMed ID: 23305422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]